Sei Muraoka

426 total citations
25 papers, 291 citations indexed

About

Sei Muraoka is a scholar working on Rheumatology, Immunology and Oncology. According to data from OpenAlex, Sei Muraoka has authored 25 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 8 papers in Immunology and 7 papers in Oncology. Recurrent topics in Sei Muraoka's work include Systemic Lupus Erythematosus Research (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). Sei Muraoka is often cited by papers focused on Systemic Lupus Erythematosus Research (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). Sei Muraoka collaborates with scholars based in Japan, United States and Slovenia. Sei Muraoka's co-authors include Shinichi Kawai, Toshihiro Nanki, Kaichi Kaneko, Natsuko Kusunoki, Hiroshi Takahashi, Kazuaki Tsuchiya, Toshio Imai, Yoshikiyo Akasaka, Hiroshi Sato and Shinichiro Nishio and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Annals of the Rheumatic Diseases and Transplantation.

In The Last Decade

Sei Muraoka

24 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sei Muraoka Japan	9	87	82	73	57	57	25	291
Iván Posso‐Osorio Colombia	11	112 1.3×	150 1.8×	52 0.7×	24 0.4×	28 0.5×	55	326
Seiji Segawa Japan	12	179 2.1×	78 1.0×	76 1.0×	65 1.1×	26 0.5×	17	320
Takuma Tsuzuki Wada Japan	8	69 0.8×	138 1.7×	129 1.8×	39 0.7×	19 0.3×	20	351
Izumi Kurata Japan	10	119 1.4×	107 1.3×	41 0.6×	23 0.4×	29 0.5×	19	268
Shinichiro Nakachi Japan	10	177 2.0×	93 1.1×	50 0.7×	73 1.3×	23 0.4×	11	342
Iwona Brzosko Poland	8	125 1.4×	146 1.8×	39 0.5×	30 0.5×	28 0.5×	28	276
Shuhong Chi China	11	132 1.5×	113 1.4×	99 1.4×	35 0.6×	34 0.6×	25	334
Lidia Ostanek Poland	9	139 1.6×	154 1.9×	47 0.6×	28 0.5×	32 0.6×	39	296
Nishanthi Thalayasingam United Kingdom	7	103 1.2×	97 1.2×	98 1.3×	31 0.5×	39 0.7×	10	308
Yuzhou Gan China	10	105 1.2×	130 1.6×	48 0.7×	29 0.5×	91 1.6×	25	274

Countries citing papers authored by Sei Muraoka

Since Specialization

Citations

This map shows the geographic impact of Sei Muraoka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sei Muraoka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sei Muraoka more than expected).

Fields of papers citing papers by Sei Muraoka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sei Muraoka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sei Muraoka. The network helps show where Sei Muraoka may publish in the future.

Co-authorship network of co-authors of Sei Muraoka

This figure shows the co-authorship network connecting the top 25 collaborators of Sei Muraoka. A scholar is included among the top collaborators of Sei Muraoka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sei Muraoka. Sei Muraoka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Wu, Qi, M. Asif Amin, Pei‐Suen Tsou, et al.. (2024). Activation of cytotoxic lymphocytes through CD6 enhances killing of cancer cells. Cancer Immunology Immunotherapy. 73(2). 34–34. 6 indexed citations

2.

Kaneko, Kaichi, Sei Muraoka, Hiroshi Sato, et al.. (2024). Comparison of Efficacy of Romosozumab With Denosumab and Risedronate in Patients Newly Initiating Glucocorticoid Therapy. The Journal of Clinical Endocrinology & Metabolism. 110(8). e2778–e2786. 2 indexed citations

3.

Muraoka, Sei, Wataru Hirose, Hajime Kono, et al.. (2024). Long-term effects of abatacept on atherosclerosis and arthritis in older vs. younger patients with rheumatoid arthritis: 3-year results of a prospective, multicenter, observational study. Arthritis Research & Therapy. 26(1). 87–87. 3 indexed citations

4.

Amin, M. Asif, Phillip L. Campbell, Qi Wu, et al.. (2022). Inhibition of bromodomain extraterminal histone readers alleviates skin fibrosis in experimental models of scleroderma. JCI Insight. 7(9). 12 indexed citations

5.

Sugihara, Takahiko, Junichi Asano, Midori Sato, et al.. (2022). Clinical characteristics of COVID-19 patients with underlying rheumatic diseases in Japan: data from a multicenter observational study using the COVID-19 Global Rheumatology Alliance physician-reported registry. Clinical Rheumatology. 41(12). 3661–3673. 4 indexed citations

6.

Muraoka, Sei, Wataru Hirose, Hajime Kono, et al.. (2021). Abatacept is Efficacious in the Treatment of Older Patients with csDMARD-Refractory Rheumatoid Arthritis: A Prospective, Multicenter, Observational Study. Rheumatology and Therapy. 8(4). 1585–1601. 10 indexed citations

7.

Mizutani, Satoshi, Junko Nishio, Kanoh Kondo, et al.. (2021). Treatment with an Anti-CX3CL1 Antibody Suppresses M1 Macrophage Infiltration in Interstitial Lung Disease in SKG Mice. Pharmaceuticals. 14(5). 474–474. 11 indexed citations

8.

Muraoka, Sei, Kaichi Kaneko, Kaori Motomura, Junko Nishio, & Toshihiro Nanki. (2021). CX3CL1/fractalkine regulates the differentiation of human peripheral blood monocytes and monocyte-derived dendritic cells into osteoclasts. Cytokine. 146. 155652–155652. 8 indexed citations

9.

Muraoka, Sei, Junko Nishio, Yoshikazu Kuboi, Toshio Imai, & Toshihiro Nanki. (2020). Rationale for and clinical development of anti-fractalkine antibody in rheumatic diseases. Expert Opinion on Biological Therapy. 20(11). 1309–1319. 8 indexed citations

10.

Kaneko, Kaichi, Satoshi Mizutani, Hiroshi Satō, et al.. (2019). Efficacy of mycophenolate mofetil in Japanese patients with systemic lupus erythematosus. Clinical Rheumatology. 38(6). 1571–1578. 7 indexed citations

11.

Muraoka, Sei, et al.. (2018). Successful Treatment of IgA Vasculitis Complicated with Bowel Perforation and Crescentic Glomerulonephritis by Combination Therapy of Glucocorticoid, Cyclosporine and Factor XIII Replacement. Internal Medicine. 57(20). 3035–3040. 6 indexed citations

12.

Sato, Hiroshi, Sei Muraoka, Natsuko Kusunoki, et al.. (2017). Resistin upregulates chemokine production by fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Research & Therapy. 19(1). 263–263. 57 indexed citations

13.

Hasunuma, Tomoko, Kenji Takagi, Sei Muraoka, et al.. (2014). A Feasibility Study Assessing Tolerability of Daily versus Twice Weekly Trimethoprim-Sulfamethoxazole Regimen for Prophylaxis against Pneumocystis Pneumonia in Patients with Systemic Autoimmune Diseases on Glucocorticoid Therapy. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 45(3). 89–92. 4 indexed citations

14.

Muraoka, Sei, Natsuko Kusunoki, Hiroshi Takahashi, Kazuaki Tsuchiya, & Shinichi Kawai. (2013). Leptin stimulates interleukin-6 production via janus kinase 2/signal transducer and activator of transcription 3 in rheumatoid synovial fibroblasts.. PubMed. 31(4). 589–95. 26 indexed citations

15.

Kaneko, Kaichi, et al.. (2010). Exacerbation of adult‐onset Still’s disease, possibly related to elevation of serum tumor necrosis factor‐alpha after etanercept administration. International Journal of Rheumatic Diseases. 13(4). e67–9. 26 indexed citations

16.

Muraoka, Sei, Yuji Ito, Masanori Baba, et al.. (2009). Effective Induction of Cell Death on Adult T-Cell Leukaemia Cells by HLA-DR -Specific Small Antibody Fragment Isolated from Human Antibody Phage Library. The Journal of Biochemistry. 145(6). 799–810. 8 indexed citations

17.

Nishio, Shinichiro, et al.. (2009). Pharmacokinetic study and Fcγ receptor gene analysis in two patients with rheumatoid arthritis controlled by low-dose infliximab. Modern Rheumatology. 19(3). 329–333. 19 indexed citations

18.

Nishio, Shinichiro, et al.. (2009). Pharmacokinetic study and Fcγ receptor gene analysis in two patients with rheumatoid arthritis controlled by low-dose infliximab. Modern Rheumatology. 19(3). 329–333. 15 indexed citations

19.

Isobe, Kazutoshi, Sei Muraoka, Keishi Sugino, et al.. (2007). [Case of pulmonary aspergillosis associated with inappropriate antidiuretic hormone syndrome caused by voriconazole therapy].. PubMed. 45(6). 489–93. 6 indexed citations

20.

Kawahara, Katsunobu, Tsutomu Tagawa, Takao Takahashi, et al.. (1993). THE EFFECT OF THE PLATELET-ACTIVATING FACTOR INHIBITOR TCV-309 ON REPERFUSION INJURY IN A CANINE MODEL OF ISCHEMIC LUNG. Transplantation. 55(6). 1438–1438. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact